Actively Recruiting
In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells
Led by Mayo Clinic · Updated on 2026-02-25
20
Participants Needed
1
Research Sites
539 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot study will first establish the feasibility of an in vivo methodology of assessing the utilization of glutamine into the TCA cycle of normal bone marrow plasma cells from healthy subjects while comparing it to an ex vivo approach
CONDITIONS
Official Title
In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 18 to 60 years
- Able to provide written consent
You will not qualify if you...
- Renal failure
- Pregnancy
- Active steroid use
- Active liver disease
- Anemia (Hemoglobin < 12.5 g/dL in men and < 11.5 g/dL in women)
- History of alcohol use (average more than 2 drinks per day)
- Body mass index (BMI) over 30
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
W
Wilson Gonsalves
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here